Ireland - English - HPRA (Health Products Regulatory Authority)

organon laboratories limited - follicle-stimulating hormone, human luteinising hormone - pdr+solv for soln for inj

Ireland - English - HPRA (Health Products Regulatory Authority)

organon laboratories limited - follicle-stimulating hormone, human luteinising hormone - pdr+solv for soln for inj

India - English - Central Drugs Standard Control Organization

infar - menotrophin (fsh & lh 1:1) - inj - 75iu. - 1amp+solv

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - luteinising hormone, human 150 iu/ml (ex netherlands & belgium); menotrophin 150 iu/ml (is a mixture of fsh & lh ex netherlands&belgium) - injection with diluent - 150,150iu/ml - active: luteinising hormone, human 150 iu/ml (ex netherlands & belgium) menotrophin 150 iu/ml (is a mixture of fsh & lh ex netherlands&belgium) excipient: chorionic gonadotrophin luteinising hormone, human

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - luteinising hormone, human 75 iu/ml (ex netherlands & belgium); menotrophin 75 iu/ml (is a mixture of fsh & lh ex netherlands&belgium) - injection with diluent - 75,75iu/ml - active: luteinising hormone, human 75 iu/ml (ex netherlands & belgium) menotrophin 75 iu/ml (is a mixture of fsh & lh ex netherlands&belgium) excipient: chorionic gonadotrophin sodium chloride

Egypt - English - EDA (Egyptian Drug Authority)

organon-holland - injection - 75 i.u./ml

Canada - English - Health Canada

organon canada ltd ltee - follicle stimulating hormone (fsh); luteinizing hormone; sodium chloride - liquid - 75unit; 75unit; .9% - follicle stimulating hormone (fsh) 75unit; luteinizing hormone 75unit; sodium chloride .9% - gonadotropins and antigonadotropins

Israel - English - Ministry of Health

organon pharma israel ltd., israel - follitropin beta - solution for injection - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - follitropin beta, quantity: 833 iu/ml - injection, solution - excipient ingredients: sucrose; sodium citrate dihydrate; polysorbate 20; benzyl alcohol; methionine; hydrochloric acid; sodium hydroxide; water for injections - female: anovulatory infertility and; controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in vitro fertilisation and related procedures). male: for the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - follitropin beta, quantity: 833 iu/ml - injection, solution - excipient ingredients: sucrose; sodium citrate dihydrate; polysorbate 20; benzyl alcohol; methionine; hydrochloric acid; sodium hydroxide; water for injections - in the female: anovulatory infertility and; controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in vitro fertilisation and related procedures). in the male: for the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.